PL357471A1 - Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene - Google Patents

Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene

Info

Publication number
PL357471A1
PL357471A1 PL00357471A PL35747100A PL357471A1 PL 357471 A1 PL357471 A1 PL 357471A1 PL 00357471 A PL00357471 A PL 00357471A PL 35747100 A PL35747100 A PL 35747100A PL 357471 A1 PL357471 A1 PL 357471A1
Authority
PL
Poland
Prior art keywords
short stature
shox
gene
methods
disorders related
Prior art date
Application number
PL00357471A
Other languages
Polish (pl)
Inventor
Ercole Rao
Original Assignee
Rappold-Hoerbrand Gudrun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22594056&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL357471(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rappold-Hoerbrand Gudrun filed Critical Rappold-Hoerbrand Gudrun
Publication of PL357471A1 publication Critical patent/PL357471A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL00357471A 1999-11-09 2000-11-08 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene PL357471A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16434199P 1999-11-09 1999-11-09
PCT/IB2000/001612 WO2001034181A2 (en) 1999-11-09 2000-11-08 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene

Publications (1)

Publication Number Publication Date
PL357471A1 true PL357471A1 (en) 2004-07-26

Family

ID=22594056

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00357471A PL357471A1 (en) 1999-11-09 2000-11-08 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene

Country Status (8)

Country Link
EP (1) EP1227832A2 (en)
JP (1) JP2003513934A (en)
AU (1) AU1292201A (en)
CA (1) CA2390632A1 (en)
CZ (1) CZ20021718A3 (en)
HU (1) HUP0204116A3 (en)
PL (1) PL357471A1 (en)
WO (1) WO2001034181A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062555A2 (en) * 2003-01-13 2004-07-29 Gudrun Rappold-Hoerbrand Use of natriuretic peptides for the treatment of stature disorders related to the shox gene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824642A (en) * 1994-04-07 1998-10-20 Genentech, Inc. Treatment of partial growth hormone insensitivity syndrome
US5631225A (en) * 1994-10-13 1997-05-20 Novo Nordisk A/S Pharmaceutical formulation

Also Published As

Publication number Publication date
AU1292201A (en) 2001-06-06
JP2003513934A (en) 2003-04-15
CA2390632A1 (en) 2001-05-17
CZ20021718A3 (en) 2002-11-13
WO2001034181A3 (en) 2001-12-06
HUP0204116A2 (en) 2003-03-28
WO2001034181A2 (en) 2001-05-17
HUP0204116A3 (en) 2005-07-28
EP1227832A2 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
IL153425A0 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
AU6910600A (en) Methods for the treatment of mental disorders
IL141263A0 (en) Methods for treatment of neurological disorders
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU3760400A (en) Methods and reagents for the diagnosis and treatment of multiple sclerosis
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
HK1042523A1 (en) Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
AU3757300A (en) Method of treating anxiety disorders
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
HUP0102886A3 (en) Treatment of anxiety disorders
AUPP870999A0 (en) Method of treatment of equine disease
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
HUP0204116A3 (en) Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene
AU2566201A (en) Compounds and methods for the treatment of pain
AU5855899A (en) Method for identifying substances for the treatment of c-jun-mediated disorders
WO2001011039A3 (en) New sequence variants of the human 1-adrenoreceptor gene and use thereof
AU1081701A (en) Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)